| Income Statement |
| Total Revenue | 18.84M |
|
| Revenues (USD) | 18.84M |
| Cost of Revenue | 10.82M |
| Gross Profit | 8.02M |
| Operating Expenses | 9.23M |
| Research and Development Expense | 3.65M |
| Selling, General and Administrative Expense | 5.58M |
| Operating Income | -1.21M |
| Income Tax Expense | -1.85M |
| Net Income | 1.39M |
| Net Income Common Stock | 1.39M |
| Net Income Common Stock (USD) | 1.39M |
| Consolidated Income | 1.39M |
| Earnings per Basic Share | 0.05 |
| Earnings per Basic Share (USD) | 0.05 |
| Earnings per Diluted Share | 0.05 |
| Earning Before Interest & Taxes (EBIT) | -455.00K |
| Earning Before Interest & Taxes (USD) | -455.00K |
| Weighted Average Shares | 31.88M |
| Weighted Average Shares Diluted | 31.88M |
| Balance Sheet |
| Cash and Equivalents | 116.36M |
| Cash and Equivalents (USD) | 116.36M |
| Trade and Non-Trade Receivables | 17.47M |
| Current Assets | 184.45M |
| Property, Plant & Equipment Net | 17.84M |
| Total Assets | 246.69M |
| Debt Current | 626.00K |
| Total Debt | 9.88M |
| Current Liabilities | 17.86M |
| Debt Non-Current | 9.26M |
| Total Liabilities | 27.18M |
| Accumulated Retained Earnings (Deficit) | -30.19M |
| Accumulated Other Comprehensive Income | -105.00K |
| Shareholders Equity | 219.51M |
| Shareholders Equity (USD) | 219.51M |
| Assets Non-Current | 62.25M |
| Total Debt (USD) | 9.88M |
| Deferred Revenue | 5.23M |
| Goodwill and Intangible Assets | 20.27M |
| Inventory | 41.35M |
| Liabilities Non-Current | 9.33M |
| Trade and Non-Trade Payables | 6.75M |
| Tax Assets | 23.83M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 877.00K |
| Net Cash Flow from Financing | 77.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 79.45M |
| Capital Expenditure | -134.00K |
| Issuance (Purchase) of Equity Shares | 77.76M |
| Net Cash Flow from Investing | -134.00K |
| Net Cash Flow from Operations | 1.83M |
| Effect of Exchange Rate Changes on Cash | -15.00K |
| Share Based Compensation | 1.87M |